Evidence map›Paper›PMID 38268908›Full record

ArticleFood science & nutrition2024

Active compounds from

Xuanming Zhang, Rongchun Wang, Nataliya Finiuk, Rostyslav Stoika, Houwen Lin, Xue Wang, Meng Jin

Open access · hybridAbstract read
In one paragraph

Article in Food science & nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Chronic Administration ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  3. Active compounds fromFood science & nutrition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Xuanming ZhangEngineering Research Center of Zebrafish Models for Human Diseases and Drug Screening Biology Institute, Qilu University of Technology (Shandong Academy of Sciences) Jinan China.ORCID https://orcid.org/0000-0003-1873-1533
Rongchun WangEngineering Research Center of Zebrafish Models for Human Diseases and Drug Screening Biology Institute, Qilu University of Technology (Shandong Academy of Sciences) Jinan China.
Nataliya FiniukDepartment of Regulation of Cell Proliferation and Apoptosis Institute of Cell Biology, National Academy of Sciences of Ukraine Lviv Ukraine.
Rostyslav StoikaDepartment of Regulation of Cell Proliferation and Apoptosis Institute of Cell Biology, National Academy of Sciences of Ukraine Lviv Ukraine.
Houwen LinResearch Center for Marine Drugs, State Key Laboratory of Oncogenes and Related Genes, Department of Pharmacy, School of Medicine Shanghai Jiao Tong University Shanghai China.
Xue WangEngineering Research Center of Zebrafish Models for Human Diseases and Drug Screening Biology Institute, Qilu University of Technology (Shandong Academy of Sciences) Jinan China.
Meng JinEngineering Research Center of Zebrafish Models for Human Diseases and Drug Screening Biology Institute, Qilu University of Technology (Shandong Academy of Sciences) Jinan China.
Qilu University of Technology · CNNational Academy of Sciences of Ukraine · UAShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Calendula officinalisfunctional foodLC–MS/MSneuroprotective effectsParkinson's diseasesignaling pathway

Identifiers

PMID38268908
PMCPMC10804118
OpenAlexW4388200538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.